nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alemtuzumab and tolerance: the university of wisconsin experience
|
Knechtle, Stuart J. |
|
2003 |
17 |
4S |
p. S26-S28 3 p. |
artikel |
2 |
Alemtuzumab induction and steroid avoidance in kidney and pancreas transplantation
|
Leventhal, Joseph R. |
|
2003 |
17 |
4S |
p. S16-S17 2 p. |
artikel |
3 |
CD52 antigen as a target for immunotherapy
|
Hale, Geoff |
|
2003 |
17 |
4S |
p. S8-S9 2 p. |
artikel |
4 |
Changing role of induction therapy in solid organ transplantation
|
Kaufman, Dixon B. |
|
2003 |
17 |
4S |
p. S3-S4 2 p. |
artikel |
5 |
Combined bone marrow and solid organ transplantation with alemtuzumab induction
|
Shapiro, Ron |
|
2003 |
17 |
4S |
p. S18-S19 2 p. |
artikel |
6 |
Conclusion
|
Knechtle, Stuart J. |
|
2003 |
17 |
4S |
p. S29- 1 p. |
artikel |
7 |
Contents
|
|
|
2003 |
17 |
4S |
p. F1-F2 nvt p. |
artikel |
8 |
Development and clinical use of CAMPATH® 1H
|
Waldmann, Herman |
|
2003 |
17 |
4S |
p. S5-S7 3 p. |
artikel |
9 |
Editorial
|
Knechtle, Stuart J. |
|
2003 |
17 |
4S |
p. S1- 1 p. |
artikel |
10 |
Immunologic monitoring of the transplant recipient: challenges and approaches with antibody induction
|
Hale, Douglas A. |
|
2003 |
17 |
4S |
p. S20-S25 6 p. |
artikel |
11 |
Initial experience with alemtuzumab in renal transplantation
|
Calne, Roy |
|
2003 |
17 |
4S |
p. S10-S11 2 p. |
artikel |
12 |
Introduction to new horizons in antibody induction therapy symposium
|
Kaufman, Dixon B. |
|
2003 |
17 |
4S |
p. S2- 1 p. |
artikel |
13 |
Long-term immunologic effects of alemtuzumab: immune reconstitution and immune function after alemtuzumab therapy for autoimmune disease
|
Isaacs, John D. |
|
2003 |
17 |
4S |
p. S12-S15 4 p. |
artikel |